Selective expansion of influenza a virus-specific T cells in symptomatic human carotid artery atherosclerotic plaques

TT Keller, JJ van der Meer, P Teeling, K van der Sluijs, MM Idu, Guus Rimmelzwaan, M Levi, AC van der Wal, OJ de Boer

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)

Abstract

Background and Purpose-Evidence is accumulating that infection with influenza A virus contributes to atherothrombotic disease. Vaccination against influenza decreases the risk of atherosclerotic syndromes, indicating that inflammatory mechanisms may be involved. We tested the hypothesis that influenza A virus-specific T cells contribute to atherosclerotic plaque inflammation, which mediates the onset of plaque rupture. Methods-T-cell cultures were generated from atherosclerotic segments and peripheral blood of 30 patients with symptomatic carotid artery disease. The response of plaque and peripheral blood T cells to influenza A virus was analyzed and expressed as a stimulation index (SI). Selective outgrowth of intraplaque influenza A-specific T cells was calculated by the ratio of plaque T cell SI and peripheral blood T cell SI for each patient. Accordingly, the patients were categorized as high- (SI ratio >= 5), intermediate- (5 < SI ratio <= 2), and non- (SI ratio < 2) responders. The presence of influenza A virus in the vessel fragments was evaluated by reverse transcription-polymerase chain reaction. Results-High proliferative responses of plaque-derived T cells to influenza A virus were frequently observed. Among the 30 patients, 5 were categorized as high responders, 10 were intermediate responders, and 15 were nonresponders. Live influenza A virus could not be detected in the atherosclerotic plaques by polymerase chain reaction. Conclusions-Selective outgrowth of influenza A virus-specific T cells occurs within the microenvironment of human atherosclerotic plaques. Influenza virus-derived antigens or alternatively, mimicry antigens, appear to be potential candidates for triggering or sustaining plaque inflammation, which eventually leads to symptomatic plaque complications.
Original languageUndefined/Unknown
Pages (from-to)174-179
Number of pages6
JournalStroke
Volume39
Issue number1
DOIs
Publication statusPublished - 2008

Cite this